Receptor activator of NF-?B ligand, macrophage inflammatory protein-1?, and the proteasome

This publication has 24 references indexed in Scilit:

• RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution
  Annual Review of Immunology, 2002
• Chemokine receptors: multifaceted therapeutic targets
  Nature Reviews Immunology, 2002
• Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease
  Journal of Clinical Investigation, 2001
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  Blood, 2001
• Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression
  Proceedings of the National Academy of Sciences, 2001
• Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand
  Blood, 2001
• Chemokines and disease
  Nature Immunology, 2001
• The 5TMM series: a useful in vivo mouse model of human multiple myeloma
  The Hematology Journal, 2000
• The TRAIL to selective tumor death
  Nature Medicine, 1999
• Myeloma bone disease
  European Journal Of Cancer, 1998